Evolution of appetite regulating systems: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Gareth Leng
No edit summary
imported>Gareth Leng
Line 7: Line 7:
{{Image|POMC structure.jpg|right|450px|'''POMC and its post-translational processing''', adapted from Millington, and Raffin-Sanson ''et al.''}}  
{{Image|POMC structure.jpg|right|450px|'''POMC and its post-translational processing''', adapted from Millington, and Raffin-Sanson ''et al.''}}  


The human POMC gene encodes a hormone precursor protein, which itself is then cleaved, with the help of prohormone convertase enzymes, into a number of different peptides. These include the melanocyte-stimulating hormones (alpha-, beta-, gamma- MSH), [[adrenocorticotropic hormone]] (ACTH), the lipotropins, and [[beta-endorphin]] <ref name=Yang03>Yang YK ''et al.'' (2003) Recent developments in our understanding of melanocortin system in the regulation of food intake. ''Obesity Rev'' 4:239-48 PMID 14649374</ref>. ACTH and the MSHs are referred to as the melanocortins and all have the same core amino acid sequence, HFRW <ref>Dores RM ''et al.'' (2005) Trends in the evolution of the proopiomelanocortin gene ''Gen Comp Endocrinol'' 142:81-93 PMID 15862552</ref>.
The human POMC gene encodes a hormone precursor protein, which itself is then cleaved, with the help of prohormone convertase enzymes, into a number of different peptides. These include the [[melanocyte-stimulating hormone]]s (alpha-, beta-, gamma- MSH), [[adrenocorticotropic hormone]] (ACTH), the [[lipotropin]]s, and [[beta-endorphin]] <ref name=Yang03>Yang YK ''et al.'' (2003) Recent developments in our understanding of melanocortin system in the regulation of food intake. ''Obesity Rev'' 4:239-48 PMID 14649374</ref>. ACTH and the MSHs are referred to as the melanocortins and all have the same core amino acid sequence, HFRW <ref>Dores RM ''et al.'' (2005) Trends in the evolution of the proopiomelanocortin gene ''Gen Comp Endocrinol'' 142:81-93 PMID 15862552</ref>.


The human POMC gene is found on chromosome 2p23<ref name=Raffin-Sanson03>Raffin-Sanson ''et al.'' (2003) Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. ''Eur J Endocrinol'' 149:79–90  PMID 12887283.</ref>, and is made up of three exons and two “large” introns<ref name=Millington07>Millington GW (2007) The role of proopiomelanocortin (POMC) neurones in feeding behaviour ''Nutrition and Metabolism'' 4:18 PMID 17764572</ref>. Only exons two and three are translated however. Exon two codes for the signal peptide and the initial N-terminal amino acids, while exon three codes for “most of the translated mRNA” <ref name=Raffin-Sanson03/>.  
The human POMC gene is found on [[chromosome]] 2p23<ref name=Raffin-Sanson03>Raffin-Sanson ''et al.'' (2003) Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. ''Eur J Endocrinol'' 149:79–90  PMID 12887283.</ref>, and is made up of three exons and two “large” introns<ref name=Millington07>Millington GW (2007) The role of proopiomelanocortin (POMC) neurones in feeding behaviour ''Nutrition and Metabolism'' 4:18 PMID 17764572</ref>. Only exons two and three are translated however. Exon two codes for the signal peptide and the initial N-terminal amino acids, while exon three codes for “most of the translated mRNA” <ref name=Raffin-Sanson03/>.  


{{Image|POMC_PC1.jpg|right|400px|''' The cleavage of POMC by PC1''' adapted from Raffin-Sanson ''et al.''}}  
{{Image|POMC_PC1.jpg|right|400px|''' The cleavage of POMC by PC1''' adapted from Raffin-Sanson ''et al.''}}  


After excision of the introns to form a “parent” POMC, this molecule is then cleaved into its various peptides, as mentioned above, by PCs, specifically PC1 and PC2<ref name=Millington07/>. These enzymes act at cleavage sites consisting of paired basic residues, arginine and lysine, and end-products of their action depend on which sites are used. As PC1 and PC2 act on different sites, and their expression varies in different tissues, processing of POMC’s peptides is tissue-specific <ref name=Raffin-Sanson03/>. For example, the anterior pituitary corticotroph cells only express PC1, which results in the cleavage of POMC into the NH2-terminal peptide (N-term), joining peptide (JP), ACTH, β-LPH, and some γ-LPH and β-endorphin (β-end) - See "POMC cleavage by PC1" diagram. The latter two peptides are produced because the “last cleavage site is only partially used”<ref name=Raffin-Sanson03/>. However, in melanotroph cells, found in the intermediate lobe of the rodent pituitary, and the human hypothalamus, and placenta, both PC1 and PC2 are expressed. This means that all the cleavage sites are used and smaller peptides are produced <ref name=Millington07/>). N-term is therefore cleaved to the γ-MSHs, ACTH gives rise to α-MSH and CLIP (corticotropin-like intermediate lobe peptide) and γ-LPH to β-MSH<ref name=Raffin-Sanson03/>.
After excision of the [[intron]]s to form a “parent” POMC, this molecule is then cleaved into its various [[peptide]]s, as mentioned above, by PCs, specifically PC1 and PC2<ref name=Millington07/>. These enzymes act at cleavage sites consisting of paired basic residues, arginine and lysine, and end-products of their action depend on which sites are used. As PC1 and PC2 act on different sites, and their expression varies in different tissues, processing of POMC peptides is tissue-specific <ref name=Raffin-Sanson03/>. For example, the anterior pituitary [[corticotroph]] cells only express PC1, which results in the cleavage of POMC into the NH2-terminal peptide (N-term), joining peptide (JP), ACTH, β-LPH, and some γ-LPH and β-endorphin (β-end) - See "POMC cleavage by PC1" diagram. The latter two peptides are produced because the “last cleavage site is only partially used”<ref name=Raffin-Sanson03/>. However, in melanotroph cells, found in the intermediate lobe of the rodent pituitary, and the human hypothalamus, and placenta, both PC1 and PC2 are expressed. This means that all the cleavage sites are used and smaller peptides are produced <ref name=Millington07/>). N-term is therefore cleaved to the γ-MSHs, ACTH gives rise to α-MSH and CLIP (corticotropin-like intermediate lobe peptide) and γ-LPH to β-MSH<ref name=Raffin-Sanson03/>.


The POMC gene is expressed in number of tissues in man and animals. These include the anterior, and intermediate (only in rodents) pituitary of the central nervous system. It is also present in the nucleus tractus solitarius of the caudal medulla, and the hypothalamus, specifically the arcuate nucleus<ref name=Millington07/>. Its expression has also been noted in the skin and the immune system<ref name=Yang03/>,as well as other peripheral tissues.
The POMC gene is expressed in number of tissues in man and animals. These include the anterior, and intermediate (only in rodents) lobes of the pituitary gland. It is also present in the nucleus tractus solitarius of the caudal medulla, and the hypothalamus, specifically the arcuate nucleus<ref name=Millington07/>. Its expression has also been noted in the skin and the immune system<ref name=Yang03/>,as well as other peripheral tissues.


The final products from the cleavage of POMC have a variety of functions. The melanocortins act on melanocortin receptors (MCRs) in different tissues. There are five types of MCR and melanocortin peptides bind to these with varying affinities<ref name=Millington07/>, for example, mainly ACTH binds to MC2R.
The final products from the cleavage of POMC have a variety of functions. The melanocortins act on melanocortin receptors (MCRs) in different tissues. There are five types of MCR and different melanocortin peptides bind to these with different affinities <ref name=Millington07/>, for example, mainly ACTH binds to MC2R.


{{Image|Table.jpg|centre|600px|'''The Melanocortin Receptors''', adapted from Yang ''et al.''}}   
{{Image|Table.jpg|centre|600px|'''The Melanocortin Receptors''', adapted from Yang ''et al.''}}   
Line 23: Line 23:
β-endorphin, on the other hand, is involved in the pain pathway by acting as an inhibitory neurotransmitter in the central nervous system. Here it binds to opioid receptors, leading to an analgesic effect<ref> Kawauchi H ''et al''. (2006) The dawn and evolution of hormones in the adenohypophysis ''Gen Comp Endocrinol'' 148:3-14 PMID 16356498.</ref> <ref>Dores RM ''et al''. (2005) Trends in the evolution of the proopiomelanocortin gene ''Gen Comp Endocrinol'' 142:81-93 PMID 15862552.</ref>.  
β-endorphin, on the other hand, is involved in the pain pathway by acting as an inhibitory neurotransmitter in the central nervous system. Here it binds to opioid receptors, leading to an analgesic effect<ref> Kawauchi H ''et al''. (2006) The dawn and evolution of hormones in the adenohypophysis ''Gen Comp Endocrinol'' 148:3-14 PMID 16356498.</ref> <ref>Dores RM ''et al''. (2005) Trends in the evolution of the proopiomelanocortin gene ''Gen Comp Endocrinol'' 142:81-93 PMID 15862552.</ref>.  


CLIP has been found in many areas of the brain, especially in nerve fibres, and has an important role in REM sleep, which in turn helps with the consolidation of memories <ref>Grigoriev VV ''et al''. (2009) Effect of Corticotropin-Like Intermediate Lobe Peptide on Presynaptic and Postsynaptic Glutamate Receptors and Postsynaptic GABA Receptors in Rat Brain ''Bull Exp Biol Med'' 147:319-22 PMID 19529852.</ref>.
CLIP is found in many areas of the brain, especially in nerve fibres, and has an important role in REM sleep, which in turn helps with the consolidation of memories <ref>Grigoriev VV ''et al''. (2009) Effect of Corticotropin-Like Intermediate Lobe Peptide on Presynaptic and Postsynaptic Glutamate Receptors and Postsynaptic GABA Receptors in Rat Brain ''Bull Exp Biol Med'' 147:319-22 PMID 19529852.</ref>.


The functions of β- and γ-LPH however, are still uncertain, although lipotropins are known for their role in lipolysis, mobilizing lipids for energy production, and their importance has been implicated in haematopoiesis<ref>Halabe Bucay A. (2008) The role of lipotropins as hematopoietic factors and their potential therapeutic use. ''Exp Hematol'' 36(6):752-4 PMID 18358591.</ref>.
The functions of β- and γ-LPH are still uncertain, although lipotropins are known for their role in lipolysis, mobilizing lipids for energy production, and their importance has been implicated in [[haematopoiesis]]<ref>Halabe Bucay A. (2008) The role of lipotropins as hematopoietic factors and their potential therapeutic use. ''Exp Hematol'' 36(6):752-4 PMID 18358591.</ref>.


=='''POMC, the Hypothalamus and Appetite Regulation'''==
=='''POMC, the Hypothalamus and Appetite Regulation'''==

Revision as of 11:29, 13 November 2010

All unapproved Citizendium articles may contain errors of fact, bias, grammar etc. A version of an article is unapproved unless it is marked as citable with a dedicated green template at the top of the page, as in this version of the 'Biology' article. Citable articles are intended to be of reasonably high quality. The participants in the Citizendium project make no representations about the reliability of Citizendium articles or, generally, their suitability for any purpose.

Attention niels epting.png
Attention niels epting.png
This article is currently being developed as part of an Eduzendium student project in the framework of a course entitled Appetite and Obesity at University of Edinburgh. The course homepage can be found at CZ:(U00984) Appetite and Obesity, University of Edinburgh 2010.
For the course duration, the article is closed to outside editing. Of course you can always leave comments on the discussion page. The anticipated date of course completion is 01 February 2011. One month after that date at the latest, this notice shall be removed.
Besides, many other Citizendium articles welcome your collaboration!


This article is developing and not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Evolution_of_appetite_regulating_systems&printable=yes
This editable Main Article is under development and subject to a disclaimer.

Recently, there has been extensive research into the neuroendocrine mechanisms controlling appetite. The pro-opiomelanocortin (POMC) gene has an important role in these mechanisms, particularly through production of alpha melanocyte stimulating hormone (alpha-MSH). POMC and its end-products have not only been identified in humans, but also in many other vertebrates. This has led to further research into the origins of the POMC gene and the evolution of appetite regulating systems. This article details the structure and function of the POMC gene. It highlights variations between species, allowing a potential evolutionary route, originating at a common ancestral gene, to be mapped out.

Human POMC

POMC and its post-translational processing, adapted from Millington, and Raffin-Sanson et al.

The human POMC gene encodes a hormone precursor protein, which itself is then cleaved, with the help of prohormone convertase enzymes, into a number of different peptides. These include the melanocyte-stimulating hormones (alpha-, beta-, gamma- MSH), adrenocorticotropic hormone (ACTH), the lipotropins, and beta-endorphin [1]. ACTH and the MSHs are referred to as the melanocortins and all have the same core amino acid sequence, HFRW [2].

The human POMC gene is found on chromosome 2p23[3], and is made up of three exons and two “large” introns[4]. Only exons two and three are translated however. Exon two codes for the signal peptide and the initial N-terminal amino acids, while exon three codes for “most of the translated mRNA” [3].

The cleavage of POMC by PC1 adapted from Raffin-Sanson et al.

After excision of the introns to form a “parent” POMC, this molecule is then cleaved into its various peptides, as mentioned above, by PCs, specifically PC1 and PC2[4]. These enzymes act at cleavage sites consisting of paired basic residues, arginine and lysine, and end-products of their action depend on which sites are used. As PC1 and PC2 act on different sites, and their expression varies in different tissues, processing of POMC peptides is tissue-specific [3]. For example, the anterior pituitary corticotroph cells only express PC1, which results in the cleavage of POMC into the NH2-terminal peptide (N-term), joining peptide (JP), ACTH, β-LPH, and some γ-LPH and β-endorphin (β-end) - See "POMC cleavage by PC1" diagram. The latter two peptides are produced because the “last cleavage site is only partially used”[3]. However, in melanotroph cells, found in the intermediate lobe of the rodent pituitary, and the human hypothalamus, and placenta, both PC1 and PC2 are expressed. This means that all the cleavage sites are used and smaller peptides are produced [4]). N-term is therefore cleaved to the γ-MSHs, ACTH gives rise to α-MSH and CLIP (corticotropin-like intermediate lobe peptide) and γ-LPH to β-MSH[3].

The POMC gene is expressed in number of tissues in man and animals. These include the anterior, and intermediate (only in rodents) lobes of the pituitary gland. It is also present in the nucleus tractus solitarius of the caudal medulla, and the hypothalamus, specifically the arcuate nucleus[4]. Its expression has also been noted in the skin and the immune system[1],as well as other peripheral tissues.

The final products from the cleavage of POMC have a variety of functions. The melanocortins act on melanocortin receptors (MCRs) in different tissues. There are five types of MCR and different melanocortin peptides bind to these with different affinities [4], for example, mainly ACTH binds to MC2R.

The Melanocortin Receptors, adapted from Yang et al.

β-endorphin, on the other hand, is involved in the pain pathway by acting as an inhibitory neurotransmitter in the central nervous system. Here it binds to opioid receptors, leading to an analgesic effect[5] [6].

CLIP is found in many areas of the brain, especially in nerve fibres, and has an important role in REM sleep, which in turn helps with the consolidation of memories [7].

The functions of β- and γ-LPH are still uncertain, although lipotropins are known for their role in lipolysis, mobilizing lipids for energy production, and their importance has been implicated in haematopoiesis[8].

POMC, the Hypothalamus and Appetite Regulation

In mammals, alpha MSH is generally assumed to be the main POMC product involved in appetite regulation. Alpha MSH is a potent inhibitor of appetite (anorexigenic), acting on MC3-R and MC4-R in the arcuate nucleus. In POMC null mice, alpha-MSH was found to be the most potent anorexigenic signaller.[9]

Rodents do not express beta-MSH, but evidence has been found indicating an important role for beta-MSH in human appetite regulation. A study screening for mutations in the beta-MSH region of POMC found an increased incidence of the beta-MSH variant Try221Cys in obese subjects. The variant was shown to have altered binding and signalling through MC4-R.[10]

Desacetyl-alpha-MSH is a precursor for alpha-MSH and is widely distributed in the brain.[11] Although desacetyl-alpha-MSH displays a similar potency for receptor binding to alpha-MSH, it does not affect food intake except at extremely high doses.[12]

Fig. 4 Hypothalamic Pathways involved in Appetite Regulation; adapted from Millington GWM[4], Cowley et al.[13], Cone RD[14], Cowley et al.[15], Schwartz et al[16]

The arcuate nucleus (ARC) is found at the bottom of the hypothalamus and consists of several groupings of specific neurons (see Fig. 4). There are two main populations of neurons regulating appetite; those co-expressing POMC and cocaine and amphetamine regulated transcript (CART) and those co-expressing neuropeptide Y (NPY) and agouti related peptide (AgRP). The POMC/CART neurons form part of the satiety pathway in the arcuate nucleus and neurons co-expressing NPY and AgRP are part of orexigenic signalling.[17] AgRP acts as an inverse agonist at MC3-R and MC4-R, to help stimulate feeding.[17]

POMC/CART and NPY/AgRP neuron populations both express leptin receptors (LepRb). Leptin has opposing effects on each neuron population, activating the anorexigenic POMC neurons and inhibiting the orexigenic NPY/AgRP neurons, in the arcuate nucleus. Using transgenic mice expressing green fluorescent protein (GFP), two CNS regions expressing POMC in response to leptin were found: the arcuate nucleus and the nucleus of the solitary tract (NTS).[13] Another study used transgenic mice with POMC-GFP expression and NYP-GFP expression, measuring the number of inhibitory and excitatory postsynaptic currents. Leptin deficient (ob/ob) mice were shown to have an increased excitation of NPY neurons and increased inhibition of POMC neurons compared to their wild-type littermates. Treatment with leptin lead to normalisation of the synaptic signals to wild-type levels.[18]

The full extent of the signalling between the neuron populations within the hypothalamus is not fully understood. It is thought that NPY neurons project to inhibit POMC expression, mediated through GABA.[14] Using electron microscopy, co-expression of GABA and NPY was confirmed at these nerve terminals.[13] Leptin also acts at the GABA nerve terminals to reduce the inhibition of POMC neurons.

Ghrelin mRNA has been shown to be expressed in the hyothalamus, using RT-PCR, but it is at present not clear whether the brain is a significant source of ghrelin. [19]There is some immunocytochemical evidence for ghrelin-containing axons in several hypothalamic nuclei, but at present it is thought that circulating ghrelin, secreted from the empty stomach, is the key appetite-regulating signal. Ghrelin was shown using fluorescent protein tagged NPY neurons, to increase release of NPY and AgRP, as well as increasing the GABA-mediated inhibition of POMC neurons. [15] Ghrelin is the endogenous ligand for the GHS-Receptor, which is dendely expressed in both the arcuate nucleus and the ventromedial nucleus.

There are five NPY receptors (Y1-Y5), which are also activated by the closely related peptide PYY. Using specific receptor agonists and measuring the effect on POMC mRNA levels, it was found that NPY down-regulates POMC expression through the Y2 receptor.[20] Interestingly, activation of a presynaptic Y2 autoreceptor suppresses NPY release. PYY3-36, a satiety signal released from the gut after a meal, acts as an agonist at the presynaptic Y2 receptors on the nerve terminals of NPY/AgRP/GABA neurons. This leads to suppression of NPY release and increased POMC release in the arcuate nucleus.[21]

POMC neurons involved in regulation of appetite are also found in the nucleus tractus solitarius (NTS), with projections to the paraventricular nucleus and elsewhere. Cholecystokinin (CCK) is another satiety-inducing peptide from the gut. Its effects are mediated through CCK1 receptors and vagal afferents to the NTS. Both feeding and intraperitoneal injection of CCK8 resulted in increased c-fos expression in NTS POMC neurons.[22] The PVN contains oxytocin neurons that project to the NTS, and which are part of a feedback mechanism to stomach, closing off the gastric sphincter. In addition, magnocellular oxytocin neurons in both the supraoptic nucleus and the PVN have MC4 receptors, and in response to alpha MSH can release large amounts of oxytocin from their dendrites within the hypothalamus; the magnocellular neurones are also excited by gastric distension, and by systemic administration of CCK. The sites of action of dendritically released oxytocin are not clear, but the VMH is a likely target, as it has a very high density of oxytocin receptors.

Species Variation in POMC Gene

evolutionary tree diagram Chordata (vertebrates)

~ Agnatha – Lamprey
~ Gnathostomes
~ Chondrichthyes (cartilaginous fish)
~ Osteichthyes (bony fish)
~ Subclass Actinopterygii (ray-finned fish;) - paddlefish
~ Subclass Sarcopterygii (lobe-finned fish
~ Tetrapods (mammals, birds, reptiles?)

Invertebrates

Summary/Conclusion

References

  1. ↑ 1.0 1.1 Yang YK et al. (2003) Recent developments in our understanding of melanocortin system in the regulation of food intake. Obesity Rev 4:239-48 PMID 14649374
  2. ↑ Dores RM et al. (2005) Trends in the evolution of the proopiomelanocortin gene Gen Comp Endocrinol 142:81-93 PMID 15862552
  3. ↑ 3.0 3.1 3.2 3.3 3.4 Raffin-Sanson et al. (2003) Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 149:79–90 PMID 12887283.
  4. ↑ 4.0 4.1 4.2 4.3 4.4 4.5 Millington GW (2007) The role of proopiomelanocortin (POMC) neurones in feeding behaviour Nutrition and Metabolism 4:18 PMID 17764572
  5. ↑ Kawauchi H et al. (2006) The dawn and evolution of hormones in the adenohypophysis Gen Comp Endocrinol 148:3-14 PMID 16356498.
  6. ↑ Dores RM et al. (2005) Trends in the evolution of the proopiomelanocortin gene Gen Comp Endocrinol 142:81-93 PMID 15862552.
  7. ↑ Grigoriev VV et al. (2009) Effect of Corticotropin-Like Intermediate Lobe Peptide on Presynaptic and Postsynaptic Glutamate Receptors and Postsynaptic GABA Receptors in Rat Brain Bull Exp Biol Med 147:319-22 PMID 19529852.
  8. ↑ Halabe Bucay A. (2008) The role of lipotropins as hematopoietic factors and their potential therapeutic use. Exp Hematol 36(6):752-4 PMID 18358591.
  9. ↑ Tung YCL et al. (2007) A comparative study of the central effects of specific proopiomelanocortin (POMC)-derived melanocortin peptides on food intake and body weight in POMC null mice. Endocrinology 147:5940-5947 PMID 16959830
  10. ↑ Lee YS et al. (2006) A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance Cell Metabolism 3:135-40 PMID 16459314
  11. ↑ Loh Y et al. (1980) MSH-like peptides in rat brain: identification and changes in level during development Biochem Biophys Res Commun 94:916-23 PMID 7396941
  12. ↑ Abbott et al. (2000). Investigation of the melanocyte stimulating hormones on food intake. Lack of evidence to support a role for the melanocortin-3-receptor Brain Res 869:203–10 PMID 10865075
  13. ↑ 13.0 13.1 13.2 Cowley MA et al. (2001) Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 441:480-4 PMID 11373681
  14. ↑ 14.0 14.1 Cone RD (2005) Anatomy and regulation of the central melanocortin system Nature Neurosci 8:571-8 PMID 15856065
  15. ↑ 15.0 15.1 Cowley MA et al. (2003) The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis Neuron 37:649-61 PMID 12597862
  16. ↑ Schwartz MW et al. (2000) Central nervous system control of food intake Nature 404:661-71 PMID 10766253
  17. ↑ 17.0 17.1 Dhillo WS et al. (2002) Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocytestimulating hormone in vitro in male rats J Neuroendocrinol 14:725-30 PMID 12213133
  18. ↑ Pinto S et al. (2004) Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304:110-5 PMID 15064421
  19. ↑ Kojima M et al. (1999) Ghrelin is a growth-hormone-releasing acylated from stomach Nature 402:656–60 PMID 10604470
  20. ↑ de Yebenes EG et al. (1995) Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus. Brain Research 674:112-116 PMID 7773678
  21. ↑ Batterham RL et al. (2002) Gut hormone PYY3-36 physiologically inhibits food intake. Nature 418:650-654 PMID 12167864
  22. ↑ Fan W et al. (2004) Cholecystokinin-mediated suppression of feeding involves the brainstem melanocortin system. Nature Neurosci 7(4):335-336 PMID 15034587
Retrieved from "https://citizendium.org/wiki/index.php?title=Evolution_of_appetite_regulating_systems&oldid=800018"